Drug-Induced Death Signaling Strategy Rapidly Predicts Cancer Response to Chemotherapy-Reference-Cited by-同舟云学术

Drug-Induced Death Signaling Strategy Rapidly Predicts Cancer Response to Chemotherapy

Published:2015-02 Issue:5 Volume:160 Page:977-989
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Montero Joan,Sarosiek Kristopher A.,DeAngelo Joseph D.,Maertens Ophélia,Ryan Jeremy,Ercan Dalia,Piao Huiying,Horowitz Neil S.,Berkowitz Ross S.,Matulonis Ursula,Jänne Pasi A.,Amrein Philip C.,Cichowski Karen,Drapkin Ronny,Letai Anthony

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference35 articles.

1. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity;Barretina;Nature,2012

2. Dual inhibition of PI3K and mTOR inhibits autocrine and paracrine proliferative loops in PI3K/Akt/mTOR-addicted lymphomas;Bhatt;Blood,2010

3. American Society of Clinical Oncology clinical practice guideline update on the use of chemotherapy sensitivity and resistance assays;Burstein;J. Clin. Oncol.,2011

4. Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members;Certo;Cancer Cell,2006

5. Improved survival with vemurafenib in melanoma with BRAF V600E mutation;Chapman;N. Engl. J. Med.,2011

Cited by 303 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primed for death: prognostic role of BH3--only proteins in breast cancer therapy: a systematic and meta-analysis review;Translational Medicine Communications;2024-08-22

2. Altered RNA export by SF3B1 mutants confers sensitivity to nuclear export inhibition;Leukemia;2024-07-13

3. Venetoclax resistance in acute lymphoblastic leukemia is characterized by increased mitochondrial activity and can be overcome by co-targeting oxidative phosphorylation;Cell Death & Disease;2024-07-03

4. HRK downregulation and augmented BCL-xL binding to BAK confer apoptotic protection to therapy-induced senescent melanoma cells.;2024-07-03

5. Zebrafish Xenographs in Oncology and Personalized Medicine;Molecular Biology;2024-06